Innospec Inc. $IOSP Shares Acquired by Brown Advisory Inc.

Brown Advisory Inc. increased its stake in Innospec Inc. (NASDAQ:IOSP) by 29.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 426,544 shares of the specialty chemicals company’s stock after acquiring an additional 97,129 shares during the period. Brown Advisory Inc. owned approximately 1.72% of Innospec worth $35,868,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of IOSP. Vanguard Group Inc. increased its holdings in Innospec by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 3,210,768 shares of the specialty chemicals company’s stock worth $304,220,000 after purchasing an additional 30,031 shares during the period. Allspring Global Investments Holdings LLC increased its stake in shares of Innospec by 3.3% during the second quarter. Allspring Global Investments Holdings LLC now owns 2,483,185 shares of the specialty chemicals company’s stock worth $216,211,000 after buying an additional 78,360 shares during the period. Geode Capital Management LLC raised its holdings in Innospec by 2.1% in the second quarter. Geode Capital Management LLC now owns 719,598 shares of the specialty chemicals company’s stock valued at $60,517,000 after acquiring an additional 14,463 shares in the last quarter. Nuveen LLC purchased a new position in Innospec in the first quarter worth approximately $42,966,000. Finally, Westwood Holdings Group Inc. lifted its stake in Innospec by 7.8% in the second quarter. Westwood Holdings Group Inc. now owns 412,310 shares of the specialty chemicals company’s stock worth $34,671,000 after acquiring an additional 29,900 shares during the last quarter. 96.64% of the stock is currently owned by hedge funds and other institutional investors.

Innospec Price Performance

NASDAQ IOSP opened at $75.04 on Friday. The company has a market capitalization of $1.86 billion, a price-to-earnings ratio of -2,501.33 and a beta of 0.93. Innospec Inc. has a 12 month low of $70.10 and a 12 month high of $120.00. The firm’s fifty day moving average price is $74.74 and its 200 day moving average price is $80.96.

Innospec (NASDAQ:IOSP) last released its quarterly earnings data on Wednesday, November 5th. The specialty chemicals company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.03 by $0.09. The firm had revenue of $441.90 million during the quarter, compared to the consensus estimate of $443.00 million. Innospec had a negative net margin of 0.07% and a positive return on equity of 10.28%. The firm’s revenue was down .3% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.35 earnings per share. As a group, sell-side analysts forecast that Innospec Inc. will post 6.18 earnings per share for the current year.

Innospec Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Wednesday, November 26th. Investors of record on Tuesday, November 18th were given a dividend of $0.87 per share. This represents a dividend yield of 245.0%. The ex-dividend date of this dividend was Tuesday, November 18th. Innospec’s dividend payout ratio is currently -5,800.00%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Weiss Ratings restated a “sell (d)” rating on shares of Innospec in a report on Thursday. Zacks Research lowered Innospec from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 4th. Finally, Wall Street Zen downgraded Innospec from a “buy” rating to a “hold” rating in a report on Sunday, October 19th. One analyst has rated the stock with a Strong Buy rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold”.

Insiders Place Their Bets

In other Innospec news, Director Leslie J. Parrette acquired 340 shares of the company’s stock in a transaction that occurred on Friday, November 14th. The shares were purchased at an average price of $74.09 per share, for a total transaction of $25,190.60. Following the completion of the purchase, the director directly owned 5,837 shares in the company, valued at $432,463.33. The trade was a 6.19% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 1.31% of the stock is currently owned by company insiders.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.